• RyuGenesis Pharma

    Global Leader in Injectable Biomaterials & ODM/CDMO Solutions
    We deliver advanced biomaterials such as Collagen, PDRN, PLLA, HA, and Bioceramics with GMP-certified quality — powering innovation for the future of medical aesthetics.

  • Technology Breakthroughs

    We specialize in tailoring formulations to meet specific client needs, ensuring quality and efficacy in every product. Custom Formulation Development What We Do we provide ODM/CDMO service of medical aesthetic products for clients around the world

    AI + Synthetic Biology

    High-throughput enzyme design platform, enhancing immune safety by efficiently removing impurity proteins and telopeptides.

    Our team navigates the complexities of regulatory requirements, providing guidance to ensure compliance across markets. Regulatory Compliance What We Do we provide ODM/CDMO service of medical aesthetic products for clients around the world

    Semiconductor-Enhanced Purification

    Innovative “charge reconstruction” technology achieves a 10x increase in raw material of aesthetic medical, eliminating endotoxins and harmful residues.

    We offer state-of-the-art manufacturing facilities with rigorous quality control to deliver safe and reliable products. Production and Quality Assurance What We Do we provide ODM/CDMO service of medical aesthetic products for clients around the world

    Generative AI for Materials Design

    Predictive modeling ensures stability, safety, and efficacy in next-generation aesthetic formulations.

  • 100+

    Clients served globally

    50+

    Products developed

    10

    Global partnerships

    30+

    Research and development projects

  • Meet Our Experts

    CEO-Dr. Gary

    • Ph.D. in Biomedical Materials, University of Pennsylvania; Visiting Scholar, University of Cambridge.
    • Led major R&D programs funded by the U.S. DOE; Reviewers of top journals in material.
    • Nearly 10 years of experience in biomaterials innovation and strategic management.

    Senior Research Specialist – Dr. Hayate

    • Ph.D. in Materials Science, Tohoku University, Japan, with 30+ years in nanomaterials and biomaterials.
    • Former Senior R&D Engineer, Nippon Steel Chemical; R&D Director, Teijin Limited.
    • Pioneer in 3D nanostructure control technologies for advanced aesthetic skincare materials.

    Head of AI-Driven Synthetic Biology – Dr. Ethan

    • Former R&D Director at Absci (NASDAQ: ABSI), leading AI-powered high-throughput strain engineering.
    • Drove the development of orthogonal translation systems and Bionic Protein™ integration, supporting a $610M collaboration with Merck.

  • Our Core Values

    Guiding principles that shape our company culture.

    💡 Craftsmanship & Innovation

    🤝 Client-Centric Collaboration

    🛡️ Integrity & Long-Termism

  • Publications in Journals

  • Science-Driven Innovation

    International Patents

    International Patents

    GMP Labs

    GMP Labs

    GMP Labs

    GMP Labs

    Global Collaborations

    Global Collaborations

  • Request a Quote Get Started Today

    1-12, Minamidoda-machi, Kawasaki-ku, Kawasaki City, Kanagawa Prefecture
    +44 7436 243261
    +44 7436 243261
    ryugenesispharma-biz@outlook.com
Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More